Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2433) 2433
Book Review (398) 398
Publication (209) 209
Book Chapter (3) 3
Magazine Article (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Data Set (1) 1
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2197) 2197
humans (1879) 1879
male (900) 900
female (897) 897
nontuberculous mycobacteria (818) 818
mycobacterium infections, nontuberculous - drug therapy (784) 784
mycobacterium infections, nontuberculous - microbiology (698) 698
middle aged (643) 643
adult (596) 596
nontuberculous mycobacteria - drug effects (590) 590
infectious diseases (577) 577
tuberculosis (561) 561
microbiology (548) 548
microbial sensitivity tests (473) 473
anti-bacterial agents - therapeutic use (460) 460
nontuberculous mycobacteria - isolation & purification (445) 445
aged (437) 437
mycobacterium infections, nontuberculous - diagnosis (432) 432
infections (406) 406
infection (372) 372
anti-bacterial agents - pharmacology (333) 333
health aspects (295) 295
respiratory system (288) 288
immunology (274) 274
animals (267) 267
diagnosis (258) 258
treatment outcome (257) 257
mycobacterium - drug effects (246) 246
disease (244) 244
clarithromycin (235) 235
bacteria (229) 229
abridged index medicus (226) 226
mycobacterium infections, nontuberculous - epidemiology (223) 223
mycobacterium infections, nontuberculous - etiology (216) 216
rapidly growing mycobacteria (208) 208
pharmacology & pharmacy (201) 201
bacterial infections and mycoses (200) 200
mycobacteria (191) 191
risk factors (189) 189
retrospective studies (188) 188
mycobacterium (187) 187
drug therapy, combination (183) 183
antitubercular agents - therapeutic use (178) 178
adolescent (175) 175
mycobacterium abscessus (167) 167
epidemiology (166) 166
research (166) 166
drug resistance, microbial (163) 163
mycobacterium tuberculosis - drug effects (161) 161
lung diseases (160) 160
care and treatment (158) 158
identification (157) 157
antitubercular agents - pharmacology (147) 147
clarithromycin - therapeutic use (147) 147
mycobacterium infections, nontuberculous - pathology (145) 145
mycobacterium chelonae - isolation & purification (144) 144
child (142) 142
mycobacterium - isolation & purification (141) 141
antibiotics (137) 137
mycobacterium infections, nontuberculous - complications (136) 136
prevalence (136) 136
drug resistance, bacterial (131) 131
mycobacterial infections (129) 129
analysis (128) 128
mycobacterium avium complex (128) 128
surgery (128) 128
aged, 80 and over (125) 125
mycobacterium infections, nontuberculous - therapy (125) 125
research article (125) 125
cystic fibrosis (123) 123
resistance (123) 123
bacterial infections (119) 119
medicine (119) 119
susceptibility (118) 118
lung diseases - microbiology (117) 117
tuberculosis, pulmonary - drug therapy (116) 116
mice (115) 115
mycobacterium infections - microbiology (115) 115
skin (115) 115
lung-disease (114) 114
drug resistance (113) 113
medicine, general & internal (113) 113
mycobacterium infections, nontuberculous - immunology (113) 113
nontuberculous mycobacteria - genetics (113) 113
sputum - microbiology (113) 113
young adult (112) 112
therapy (109) 109
patients (108) 108
dermatology (105) 105
nontuberculous mycobacteria - classification (104) 104
avium complex (103) 103
abscessus (101) 101
mycobacterium tuberculosis (101) 101
mycobacterium infections - drug therapy (100) 100
mycobacterium avium complex - drug effects (98) 98
child, preschool (96) 96
anti-bacterial agents - administration & dosage (94) 94
cystic-fibrosis (94) 94
pulmonary-disease (94) 94
mycobacterium chelonae (92) 92
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2225) 2225
Japanese (56) 56
German (35) 35
Spanish (35) 35
French (33) 33
Russian (15) 15
Chinese (12) 12
Polish (8) 8
Czech (4) 4
Portuguese (4) 4
Italian (3) 3
Dutch (2) 2
Korean (2) 2
Ukrainian (2) 2
Croatian (1) 1
Danish (1) 1
Finnish (1) 1
Norwegian (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus
by Koh, Won-Jung and Jeon, Kyeongman and Lee, Nam Yong and Kim, Bum-Joon and Kook, Yoon-Hoh and Lee, Seung-Heon and Park, Young Kil and Kim, Chang Ki and Shin, Sung Jae and Huitt, Gwen A and Daley, Charles L and Kwon, O. Jung
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 02/2011, Volume 183, Issue 3, pp. 405 - 410
Rationale: Mycobacterium massiliense has been recognized as a separate species from Mycobacterium abscessus; however, little is known regarding the clinical... 
Mycobacterium massiliense | Treatment outcome | Clarithromycin | Mycobacterium abscessus | Nontuberculous mycobacteria | DIAGNOSIS | BOLLETII | nontuberculous mycobacteria | clarithromycin | treatment outcome | CHELONAE | RAPIDLY GROWING MYCOBACTERIA | GENE | RESPIRATORY SYSTEM | DISEASE | SP-NOV | CYSTIC-FIBROSIS | MACROLIDE RESISTANCE | CRITICAL CARE MEDICINE | Sputum - microbiology | Cefoxitin - therapeutic use | Nontuberculous Mycobacteria - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Male | Treatment Outcome | Clarithromycin - therapeutic use | Mycobacterium Infections, Nontuberculous - diagnosis | Microbial Sensitivity Tests | Amikacin - therapeutic use | Mycobacterium Infections, Nontuberculous - microbiology | Antibiotics, Antitubercular - therapeutic use | Female | Retrospective Studies | Drug Therapy, Combination | Mycobacterium Infections, Nontuberculous - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Mycobacterial characteristics and treatment outcomes in mycobacterium abscessus lung disease
by Koh, Won-Jung and Jeong, Byeong-Ho and Kim, Su-Young and Jeon, Kyeongman and Park, Kyoung Un and Jhun, Byung Woo and Lee, Hyun and Park, Hye Yun and Kim, Dae Hun and Huh, Hee Jae and Ki, Chang-Seok and Lee, Nam Yong and Kim, Hong Kwan and Choi, Yong Soo and Kim, Jhingook and Lee, Seung-Heon and Kim, Chang Ki and Shin, Sung Jae and Daley, Charles L and Kim, Hojoong and Kwon, O. Jung
Clinical Infectious Diseases, ISSN 1058-4838, 2017, Volume 64, Issue 3, pp. 309 - 316
Background. Treatment outcomes of patients with Mycobacterium abscessus subspecies abscessus lung disease are poor, and the microbial characteristics... 
Lung disease | Macrolides | Mycobacterium abscessus | Nontuberculous mycobacteria | INFECTIOUS DISEASES | RESPIRATORY SPECIMENS | SUBSP ABSCESSUS | CLARITHROMYCIN RESISTANCE | nontuberculous mycobacteria | MICROBIOLOGY | lung disease | IMMUNOLOGY | ERM GENE | macrolides | ANTIBIOTIC-TREATMENT | CYSTIC-FIBROSIS | NODULAR BRONCHIECTASIS | PULMONARY-DISEASE | CLINICAL-SIGNIFICANCE | Sputum - microbiology | Recurrence | Nontuberculous Mycobacteria - drug effects | Lung Diseases - microbiology | Humans | Middle Aged | Genotype | Male | Treatment Outcome | Clarithromycin - therapeutic use | Lung Diseases - drug therapy | Nontuberculous Mycobacteria - classification | Nontuberculous Mycobacteria - isolation & purification | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Microbial | Mycobacterium Infections, Nontuberculous - microbiology | Female | Aged | Anti-Bacterial Agents - pharmacology | Retrospective Studies | Clarithromycin - pharmacology | Mycobacterium Infections, Nontuberculous - drug therapy | Nontuberculous Mycobacteria - genetics | Mycobacterium | Treatment outcome | Care and treatment | Mycobacteria | Lung diseases | Analysis | Research | Genotype & phenotype | Bacteria | Clinical outcomes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Antibiotic Treatment of Mycobacterium abscessus Lung Disease: A Retrospective Analysis of 65 Patients
by Jeon, Kyeongman and Kwon, O Jung and Lee, Nam Yong and Kim, Bum-Joon and Kook, Yoon-Hoh and Lee, Seung-Heon and Park, Young Kil and Kim, Chang Ki and Koh, Won-Jung
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 11/2009, Volume 180, Issue 9, pp. 896 - 902
Rationale: The optimal therapeutic regimen and duration of treatment for Mycobacterium abscessus lung disease is not well established. Objectives: To assess... 
Treatment outcome | Lung diseases | Mycobacterium abscessus | Atypical mycobacteria | lung diseases | DIAGNOSIS | INFECTIONS | NONTUBERCULOUS MYCOBACTERIA | CLARITHROMYCIN RESISTANCE | treatment outcome | CHELONAE | atypical mycobacteria | RAPIDLY GROWING MYCOBACTERIA | IN-VITRO | RESPIRATORY SYSTEM | MULTIDRUG-RESISTANT TUBERCULOSIS | SP-NOV | NODULAR BRONCHIECTASIS | CRITICAL CARE MEDICINE | Sputum - microbiology | Lung - microbiology | Cefoxitin - therapeutic use | Lung Diseases - microbiology | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Lung - diagnostic imaging | Lung Diseases - drug therapy | Anti-Bacterial Agents - therapeutic use | Sputum - drug effects | Liver - drug effects | Mycobacterium Infections, Nontuberculous - microbiology | Adult | Female | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Drug Therapy, Combination | Neutropenia - chemically induced | Chemical and Drug Induced Liver Injury - etiology | Doxycycline - adverse effects | Ciprofloxacin - adverse effects | Nontuberculous Mycobacteria - drug effects | Clarithromycin - adverse effects | Doxycycline - therapeutic use | Ciprofloxacin - therapeutic use | Anti-Infective Agents - therapeutic use | Treatment Outcome | Clarithromycin - therapeutic use | Thrombocytopenia - chemically induced | Nontuberculous Mycobacteria - isolation & purification | Amikacin - adverse effects | Amikacin - therapeutic use | Lung - drug effects | Cefoxitin - adverse effects | Mycobacterium Infections, Nontuberculous - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Macrolide treatment for mycobacterium abscessus and mycobacterium massiliense infection and inducible resistance
by Choi, Go-Eun and Shin, Sung Jae and Won, Choul-Jae and Min, Ki-Nam and Oh, Taegwon and Hahn, Mi-Young and Lee, Keehoon and Lee, Soo Hyun and Daley, Charles L and Kim, Seonwoo and Jeong, Byeong-Ho and Jeon, Kyeongman and Koh, Won-Jung
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 11/2012, Volume 186, Issue 9, pp. 917 - 925
Macrolides, such as clarithromycin (CLR) and azithromycin (AZM), are frequently the only oral antibiotics that are active against Mycobacterium abscessus and... 
Mycobacterium massiliense | Clarithromycin | Inducible resistance | Mycobacterium abscessus | Azithromycin | Humans | Mice, Inbred C57BL | Clarithromycin - therapeutic use | Azithromycin - pharmacology | Mycobacterium - drug effects | Mycobacterium - isolation & purification | Anti-Bacterial Agents - therapeutic use | Animals | Bone Marrow Cells | Azithromycin - therapeutic use | Mycobacterium Infections, Nontuberculous - microbiology | Drug Resistance, Multiple, Bacterial | Macrolides - pharmacology | Mycobacterium - classification | Female | Anti-Bacterial Agents - pharmacology | Mice | Mycobacterium Infections, Nontuberculous - genetics | In Vitro Techniques | Macrolides - therapeutic use | Clarithromycin - pharmacology | Mycobacterium Infections, Nontuberculous - drug therapy | Republic of Korea | Disease Models, Animal | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae
by Kevin A. Nash and Barbara A. Brown-Elliott and Richard J. Wallace Jr
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 04/2009, Volume 53, Issue 4, pp. 1367 - 1376
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
RAPIDLY GROWING MYCOBACTERIA | INFECTIONS | SMEGMATIS | NONTUBERCULOUS MYCOBACTERIA | CLARITHROMYCIN RESISTANCE | ERYTHROMYCIN | TUBERCULOSIS COMPLEX | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | RIBOSOMAL-RNA | IDENTIFICATION | MOLECULAR-BASIS | Amino Acid Sequence | Methyltransferases - chemistry | Mycobacterium chelonae - drug effects | Nontuberculous Mycobacteria - drug effects | RNA - analysis | Humans | Methyltransferases - genetics | Molecular Sequence Data | Microbial Sensitivity Tests | Mycobacterium chelonae - genetics | Polymerase Chain Reaction | Macrolides - pharmacology | Drug Resistance, Bacterial - genetics | Clarithromycin - pharmacology | Nontuberculous Mycobacteria - genetics | Index Medicus | Mechanisms of Resistance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Nitazoxanide Analogs Require Nitroreduction for Antimicrobial Activity in Mycobacterium smegmatis
by Buchieri, Maria V and Cimino, Mena and Rebollo-Ramirez, Sonia and Beauvineau, Claire and Cascioferro, Alessandro and Favre-Rochex, Sandrine and Helynck, Olivier and Naud-Martin, Delphine and Larrouy-Maumus, Gerald and Munier-Lehmann, Hélène and Gicquel, Brigitte
Journal of Medicinal Chemistry, ISSN 0022-2623, 2017, Volume 60, Issue 17, pp. 7425 - 7433
In this study, we aimed to decipher the natural resistance mechanisms of mycobacteria against novel compounds isolated by whole-cell-based high-throughput... 
INTRINSIC MACROLIDE RESISTANCE | CHEMISTRY, MEDICINAL | MEROPENEM-CLAVULANATE | GENE | TUBERCULOSIS | ESCHERICHIA-COLI | SUSCEPTIBILITY | DRUG-RESISTANCE | METRONIDAZOLE | HELICOBACTER-PYLORI | GIARDIA-LAMBLIA | Nitroreductases - genetics | Mycobacterium smegmatis - genetics | Down-Regulation | Humans | Drug Resistance, Bacterial | Mycobacterium - genetics | Mycobacterium - drug effects | Mycobacterium Infections - drug therapy | Nitroreductases - metabolism | Mycobacterium Infections, Nontuberculous - microbiology | Anti-Bacterial Agents - chemistry | Mycobacterium smegmatis - drug effects | Mycobacterium - enzymology | Mycobacterium Infections - microbiology | Thiazoles - chemistry | Anti-Bacterial Agents - pharmacology | Thiazoles - pharmacology | Mycobacterium smegmatis - enzymology | Mycobacterium Infections, Nontuberculous - drug therapy | Index Medicus | Mycobacterium | Mycobacterium smegmatis | Mycobacterium Infections | Mycobacterium Infections, Nontuberculous | Chemical Sciences | Life Sciences | Microbiology and Parasitology | Anti-Bacterial Agents | Nitroreductases | Thiazoles
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Mycobacterium arupense, Mycobacterium heraklionense, and a newly proposed species, "mycobacterium virginiense" sp. Nov., but not Mycobacterium nonchromogenicum, as species of the Mycobacterium terrae complex causing tenosynovitis and osteomyelitis
by Vasireddy, Ravikiran and Vasireddy, Sruthi and Brown-Elliott, Barbara A and Wengenack, Nancy L and Eke, Uzoamaka A and Benwill, Jeana L and Turenne, Christine and Wallace, Richard J
Journal of Clinical Microbiology, ISSN 0095-1137, 05/2016, Volume 54, Issue 5, pp. 1340 - 1351
Mycobacterium terrae complex has been recognized as a cause of tenosynovitis, with M. terrae and Mycobacterium nonchromogenicum reported as the primary... 
United States | Humans | Middle Aged | Antitubercular Agents - pharmacology | Male | Tenosynovitis - microbiology | DNA, Ribosomal - chemistry | Sequence Analysis, DNA | Mycobacterium - genetics | Microbial Sensitivity Tests | Mycobacterium - drug effects | Mycobacterium - isolation & purification | Young Adult | DNA-Directed RNA Polymerases | Mycobacterium Infections, Nontuberculous - microbiology | Osteomyelitis - microbiology | Mycobacterium - classification | RNA, Ribosomal, 16S - genetics | Adult | Female | Aged | DNA, Ribosomal - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Progression and treatment outcomes of lung disease caused by mycobacterium abscessus and mycobacterium massiliense
by Park, Jimyung and Cho, Jaeyoung and Lee, Chang-Hoon and Han, Sung Koo and Yim, Jae-Joon
Clinical Infectious Diseases, ISSN 1058-4838, 2017, Volume 64, Issue 3, pp. 301 - 308
Background. Mycobacterium abscessus and Mycobacterium massiliense are grouped as the Mycobacterium abscessus complex. The aim of this study was to elucidate... 
Mycobacterium massiliense | Treatment outcome | Mycobacterium abscessus | Disease progression | Nontuberculous mycobacteria | INFECTIOUS DISEASES | COMPLEX | nontuberculous mycobacteria | MICROBIOLOGY | disease progression | IMMUNOLOGY | KOREA | IDENTIFICATION | treatment outcome | AVIUM | THERAPY | INDUCIBLE RESISTANCE | DIFFERENTIATION | PULMONARY-DISEASE | CLINICAL-SIGNIFICANCE | Sputum - microbiology | Lung Diseases - diagnosis | Nontuberculous Mycobacteria - drug effects | Lung Diseases - microbiology | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Clarithromycin - therapeutic use | Lung Diseases - drug therapy | Disease Progression | Mycobacterium Infections, Nontuberculous - diagnosis | Azithromycin - pharmacology | Microbial Sensitivity Tests | Nontuberculous Mycobacteria - isolation & purification | Anti-Bacterial Agents - therapeutic use | Azithromycin - therapeutic use | Mycobacterium Infections, Nontuberculous - microbiology | Female | Aged | Retrospective Studies | Clarithromycin - pharmacology | Mycobacterium Infections, Nontuberculous - drug therapy | Mycobacterium | Care and treatment | Mycobacteria | Lung diseases | Research | Patients | Health aspects | Bacteria | Medical treatment | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text In Vitro Activities of DC-159a, a Novel Fluoroquinolone, against Mycobacterium Species
by Areeya Disratthakit and Norio Doi
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2010, Volume 54, Issue 6, pp. 2684 - 2686
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
GATIFLOXACIN | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | MURINE TUBERCULOSIS | MOXIFLOXACIN | Levofloxacin | Species Specificity | Humans | Aza Compounds - pharmacology | Mycobacterium fortuitum - drug effects | Mycobacterium tuberculosis - drug effects | Quinolines - pharmacology | Microbial Sensitivity Tests | Mycobacterium - isolation & purification | Mycobacterium avium Complex - isolation & purification | Ofloxacin - pharmacology | Mycobacterium chelonae - isolation & purification | Drug Resistance, Multiple, Bacterial | Mycobacterium fortuitum - isolation & purification | Mycobacterium - classification | Mycobacterium Infections - microbiology | Mycobacterium chelonae - drug effects | Nontuberculous Mycobacteria - drug effects | Antitubercular Agents - pharmacology | Mycobacterium tuberculosis - isolation & purification | Mycobacterium - drug effects | Nontuberculous Mycobacteria - isolation & purification | Mycobacterium Infections - drug therapy | Mycobacterium avium Complex - drug effects | Mycobacterium kansasii - drug effects | Aminopyridines - pharmacology | Fluoroquinolones - pharmacology | Mycobacterium kansasii - isolation & purification | Rifampin - pharmacology | In Vitro Techniques | Index Medicus | Susceptibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Clofazimine prevents the regrowth of Mycobacterium abscessus and Mycobacterium avium type strains exposed to amikacin and clarithromycin
by Ferro, Beatriz E and Meletiadis, J and Wattenberg, Melanie and De Jong, Arjan and Soolingen, Dick and Mouton, Johan and Ingen, Jakko
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2016, Volume 60, Issue 2, pp. 1097 - 1105
Multidrug therapy is a standard practice when treating infections by nontuberculous mycobacteria (NTM), but few treatment options exist. We conducted this... 
IN-VITRO | GROWING MYCOBACTERIA | PHARMACOKINETICS | TUBERCULOSIS | ANTIMICROBIAL AGENTS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | TIME-KILL KINETICS | PHARMACODYNAMICS | DRUG-RESISTANCE | INTRACELLULARE | PULMONARY-DISEASE | Mycobacterium avium - genetics | Nontuberculous Mycobacteria - drug effects | Nontuberculous Mycobacteria - growth & development | Amikacin - pharmacology | Clofazimine - pharmacology | Mycobacterium avium - drug effects | Drug Synergism | Microbial Sensitivity Tests | Drug Interactions | Anti-Bacterial Agents - pharmacology | Mutation | Drug Therapy, Combination | Clarithromycin - pharmacology | Monte Carlo Method | Mycobacterium avium - growth & development | Nontuberculous Mycobacteria - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
by Julie Jarand and Adrah Levin and Lening Zhang and Gwen Huitt and John D. Mitchell and Charles L. Daley
Clinical Infectious Diseases, ISSN 1058-4838, 3/2011, Volume 52, Issue 5, pp. 565 - 571
Background. Mycobacterium abscessus can produce a chronic pulmonary infection for which little is known regarding optimal treatment and long-term outcomes.... 
Gastroesophageal reflux | Mycobacterium | Health outcomes | Relapse | Antibiotics | Lung diseases | Sputum | Cystic fibrosis | Infections | Bronchiectasis | ARTICLES AND COMMENTARIES | INFECTIOUS DISEASES | INFECTIONS | COMPLEX | PNEUMONECTOMY | NONTUBERCULOUS MYCOBACTERIA | MACROPHAGES | MICROBIOLOGY | PREVALENCE | IMMUNOLOGY | CT FINDINGS | RAPIDLY GROWING MYCOBACTERIA | LUNG-DISEASE | CYSTIC-FIBROSIS | Pneumonia, Bacterial - microbiology | Humans | Middle Aged | Male | Treatment Outcome | Mycobacterium - drug effects | Mycobacterium - isolation & purification | Anti-Bacterial Agents - therapeutic use | Debridement | Mycobacterium Infections - drug therapy | Pneumonia, Bacterial - surgery | Mycobacterium Infections - surgery | Aged, 80 and over | Adult | Female | Mycobacterium Infections - microbiology | Pneumonia, Bacterial - drug therapy | Aged | Retrospective Studies | Chronic Disease | Care and treatment | Usage | Patient outcomes | Mycobacteria | Health aspects | Bacteria | Chronic obstructive pulmonary disease | Medical treatment | Clinical outcomes | Index Medicus | Chest | Chronic infection | Fatigue | Thorax | Cough | Cavities | Surgery | Standard deviation | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Nontuberculous mycobacterial ocular infections - Comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense
by Chu, Hsiao-Sang and Chang, Shan-Chwen and Shen, Elizabeth P and Hu, Fung-Rong
PLoS ONE, ISSN 1932-6203, 01/2015, Volume 10, Issue 1, pp. e0116236 - e0116236
Purpose To analyze the clinical characteristics of nontuberculous mycobacterial (NTM) ocular infections and the species-specific in vitro antimicrobial... 
ANTIMICROBIAL SUSCEPTIBILITY | MULTIDISCIPLINARY SCIENCES | KERATITIS | PENETRATION | UPDATE | COHORT | IDENTIFICATION | Nontuberculous Mycobacteria - drug effects | Anti-Infective Agents - pharmacology | Humans | Middle Aged | Anti-Infective Agents - therapeutic use | Drug Resistance, Bacterial | Clarithromycin - therapeutic use | Amikacin - pharmacology | Eye Infections, Bacterial - drug therapy | Microbial Sensitivity Tests | Nontuberculous Mycobacteria - isolation & purification | Young Adult | Amikacin - therapeutic use | Eye Infections, Bacterial - microbiology | Mycobacterium Infections, Nontuberculous - microbiology | Adolescent | Aged, 80 and over | Adult | Aged | Child | Clarithromycin - pharmacology | Mycobacterium Infections, Nontuberculous - drug therapy | Infection | Levofloxacin | Microbiology | Ciprofloxacin | Health aspects | Fluoroquinolones | Clarithromycin | Keratitis | Amikacin | Laboratories | Taxonomy | Heat shock proteins | Antimicrobial agents | Infections | Identification | Moxifloxacin | Drug resistance | Antiinfectives and antibacterials | Clinical outcomes | Hospitals | Gatifloxacin | Surgery | RpoB protein | Titration | Species | Deoxyribonucleic acid--DNA | Hsp65 protein | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Matrix-assisted laser desorption ionization-time of flight mass spectrometry for combined species identification and drug sensitivity testing in mycobacteria
by Ceyssens, Pieter-Jan and Soetaert, Karine and Timke, Markus and Bossche, An Van Den and Sparbier, Katrin and De Cremer, Koen and Kostrzewa, Markus and Hendrickx, Marijke and Mathys, Vanessa
Journal of Clinical Microbiology, ISSN 0095-1137, 02/2017, Volume 55, Issue 2, pp. 624 - 634
Species identification and drug susceptibility testing (DST) of mycobacteria are important yet complex processes traditionally reserved for reference... 
MBT-ASTRA | Drug susceptibility testing | MALDI-TOF | Mycobacteria | SYSTEM | DIAGNOSIS | PROBE ASSAY | TUBERCULOSIS | PERFORMANCE | MICROBIOLOGY | drug susceptibility testing | mycobacteria | MALDI-TOF MS | IDENTIFY NONTUBERCULOUS MYCOBACTERIA | RESISTANCE | MOLECULAR EPIDEMIOLOGY | RAPID IDENTIFICATION | Nontuberculous Mycobacteria - isolation & purification | Mycobacterium tuberculosis - classification | Nontuberculous Mycobacteria - drug effects | Bacteriological Techniques - methods | Humans | Antitubercular Agents - pharmacology | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization - methods | Mycobacterium tuberculosis - drug effects | Mycobacterium tuberculosis - isolation & purification | Nontuberculous Mycobacteria - classification | Index Medicus | Mycobacteriology and Aerobic Actinomycetes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Lack of antimicrobial bactericidal activity in Mycobacterium abscessus
by Maurer, Florian P and Bruderer, Vera L and Ritter, Claudia and Castelberg, Claudio and Bloemberg, Guido V and Böttger, Erik C
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 2014, Volume 58, Issue 7, pp. 3828 - 3836
Antibiotic therapy of infections caused by the emerging pathogen Mycobacterium abscessus is challenging due to the organism's natural resistance toward most... 
ERM | MUTANTS | TRANSMISSION | SMEGMATIS | MODIFYING ENZYME | GENE | CLARITHROMYCIN RESISTANCE | SUSCEPTIBILITY | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | CYSTIC-FIBROSIS | CHELONAE | Dose-Response Relationship, Drug | Microbial Sensitivity Tests | Mycobacterium smegmatis - growth & development | Nontuberculous Mycobacteria - drug effects | Escherichia coli - drug effects | Mycobacterium smegmatis - drug effects | Drug Resistance, Bacterial | Acetyltransferases - antagonists & inhibitors | Anti-Bacterial Agents - pharmacology | Kinetics | Nontuberculous Mycobacteria - growth & development | Index Medicus | Mechanisms of Resistance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Treatment of mycobacterium abscessus infection
by Novosad, Shannon A and Beekmann, Susan E and Polgreen, Philip M and Mackey, Kate and Winthrop, Kevin L and M Abscessus Study Team and M. abscessus Study Team
Emerging Infectious Diseases, ISSN 1080-6040, 03/2016, Volume 22, Issue 3, pp. 511 - 514
Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effective drugs or dosing regimens are limited. To better... 
INFECTIOUS DISEASES | IMMUNOLOGY | Anti-Infective Agents - adverse effects | Nontuberculous Mycobacteria - drug effects | Humans | Middle Aged | Anti-Infective Agents - therapeutic use | Male | Treatment Outcome | Mycobacterium Infections, Nontuberculous - epidemiology | Anti-Infective Agents - administration & dosage | Mycobacterium Infections, Nontuberculous - microbiology | Adult | Female | Aged | Drug Therapy, Combination | Mycobacterium Infections, Nontuberculous - drug therapy | Infection | Drug resistance in microorganisms | Respiratory tract diseases | Care and treatment | Health aspects | Index Medicus | treatment | therapeutics | bacteria | Nontuberculous mycobacteria | adverse effects | tuberculosis and other mycobacteria | Dispatch | Treatment of | Mycobacterium abscessus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Distinguishing nontuberculous mycobacteria from multidrug-resistant Mycobacterium tuberculosis, China
by Xu, Kaijin and Bi, Sheng and Ji, Zhongkang and Hu, Haiyang and Hu, Feisu and Zheng, Beiwen and Wang, Bing and Ren, Jingjing and Yang, Shigui and Deng, Min and Chen, Ping and Ruan, Bing and Sheng, Jifang and Li, Lanjuan
Emerging Infectious Diseases, ISSN 1080-6040, 2014, Volume 20, Issue 6, pp. 1060 - 1062
INFECTIOUS DISEASES | IMMUNOLOGY | BIOCHIP SYSTEM | IDENTIFICATION | SPUTUM | Sputum - microbiology | Genes, Bacterial | Diagnosis, Differential | Nontuberculous Mycobacteria - drug effects | Humans | Mycobacterium tuberculosis - drug effects | Mycobacterium Infections, Nontuberculous - diagnosis | Mycobacterium tuberculosis - isolation & purification | Tuberculosis, Multidrug-Resistant - diagnosis | Nontuberculous Mycobacteria - isolation & purification | Tuberculosis, Multidrug-Resistant - microbiology | Diagnostic Errors | Mycobacterium Infections, Nontuberculous - microbiology | China | RNA, Ribosomal, 16S - genetics | Mutation | Drug Resistance, Multiple, Bacterial - genetics | Mycobacterium Infections, Nontuberculous - drug therapy | Nontuberculous Mycobacteria - genetics | Antitubercular Agents - therapeutic use | Mycobacterium tuberculosis - genetics | Tuberculosis, Multidrug-Resistant - drug therapy | Index Medicus | Letter | nontuberculous Mycobacteria | Mycobacterium tuberculosis | tuberculosis | multidrug-resistant Mycobacterium tuberculosis | tuberculosis and other mycobacteria | Letters to the Editor | MDR TB
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Susceptibility of mycobacterium abscessus to antimycobacterial drugs in preclinical models
by Obregón-Henao, Andrés and Arnett, Kimberly A and Henao-Tamayo, Marcela and Massoudi, Lisa and Creissen, Elizabeth and Andries, Koen and Lenaerts, Anne J and Ordway, Diane J
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2015, Volume 59, Issue 11, pp. 6904 - 6912
Over the last 10 years, Mycobacterium abscessus group strains have emerged as important human pathogens, which are associated with significantly higher... 
EFFICACY | NONTUBERCULOUS MYCOBACTERIA | IMMUNE-RESPONSES | MACROPHAGES | DISEASE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INFECTION | MICE | MECHANISMS | Granulocyte-Macrophage Colony-Stimulating Factor - metabolism | Clofazimine - pharmacology | Mice, SCID | Mycobacterium Infections | Diarylquinolines - pharmacology | Granulocyte-Macrophage Colony-Stimulating Factor - genetics | Mice, Knockout | Microbial Sensitivity Tests | Mycobacterium - drug effects | Animals | Anti-Bacterial Agents - pharmacology | Mice | Clarithromycin - pharmacology | Index Medicus | Clinical Therapeutics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights